4.7 Article

Effects of a polyphenol-rich grape and blueberry extract (Memophenol™) on cognitive function in older adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study

Journal

FRONTIERS IN PSYCHOLOGY
Volume 14, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fpsyg.2023.1144231

Keywords

blueberries; grapes; mild cognition impairment; memory; polyphenols

Ask authors/readers for more resources

Research suggests that polyphenols, found in plants, can reduce the risk of cognitive decline and related dementias. A study showed that supplementation with a polyphenol-rich grape and blueberry extract improved cognitive function in older adults with mild cognitive impairment, specifically in terms of information processing speed, visuospatial learning, and executive function. However, further research is needed to confirm these findings.
BackgroundPolyphenols are naturally occurring organic compounds found in plants. Research suggests that their intake reduces the risk of cognitive decline and related dementias. Grapes and blueberries are polyphenol-rich foods that have attracted attention for their potential cognitive-enhancing effects. PurposeExamine the effects of supplementation with a standardized and patented polyphenol-rich grape and blueberry extract (Memophenol (TM)) on cognitive function in older adults with mild cognitive impairment. Study designTwo-arm, 6 month, parallel-group, randomized, double-blind, placebo-controlled trial. MethodsOne hundred and forty-three volunteers aged 60 to 80 years with mild cognitive impairment were supplemented with either 150 mg of Memophenol (TM), twice daily or a placebo. Outcome measures included computer-based cognitive tasks, the Behavior Rating Inventory of Executive Function (BRIEF-A), the Cognitive Failures Questionnaire, and the CASP-19. ResultsCompared to the placebo, Memophenol (TM) supplementation was associated with greater improvements in the speed of information processing (p = 0.020), visuospatial learning (p = 0.012), and the BRIEF-A global score (p = 0.046). However, there were no other statistically significant between-group differences in the performance of other assessed cognitive tests or self-report questionnaires. Memophenol (TM) supplementation was well-tolerated with no reports of significant adverse reactions. ConclusionThe promising results from this trial suggest that 6-months of supplementation with Memophenol (TM) may improve aspects of cognitive function in adults with mild cognitive impairment. Further research will be important to expand on the current findings and identify the potential mechanisms of action associated with the intake of this polyphenol-rich extract.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available